Published in Inflamm Res on November 01, 2004
The immune system and cardiac repair. Pharmacol Res (2008) 3.42
Matricellular proteins in cardiac adaptation and disease. Physiol Rev (2012) 2.01
The pathogenesis of cardiac fibrosis. Cell Mol Life Sci (2013) 1.96
Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. J Mol Cell Cardiol (2010) 1.73
Aging and Cardiac Fibrosis. Aging Dis (2011) 1.58
Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proc Natl Acad Sci U S A (2008) 1.48
Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovasc Res (2009) 1.38
Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin Cancer Biol (2012) 1.35
The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Fail Rev (2010) 1.30
The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart. Trends Mol Med (2011) 1.24
Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging. Microsc Microanal (2011) 1.09
TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis. J Mol Cell Cardiol (2013) 1.08
Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload. Proc Natl Acad Sci U S A (2011) 1.07
Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. J Biomed Mater Res A (2010) 1.05
Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response. Biomaterials (2012) 1.05
Chemokines and cardiac fibrosis. Front Biosci (Schol Ed) (2009) 1.03
Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Cardiovasc Res (2006) 1.00
Low oxygen tension positively influences cardiomyocyte progenitor cell function. J Cell Mol Med (2011) 0.97
Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap. Stem Cells Int (2012) 0.92
Human effector/initiator gene sets that regulate myometrial contractility during term and preterm labor. Am J Obstet Gynecol (2010) 0.87
Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? J Cardiovasc Transl Res (2012) 0.86
Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes. PLoS One (2012) 0.84
Histamine deficiency exacerbates myocardial injury in acute myocardial infarction through impaired macrophage infiltration and increased cardiomyocyte apoptosis. Sci Rep (2015) 0.83
Development and Function of Arterial and Cardiac Macrophages. Trends Immunol (2016) 0.81
Green tea epigallo-catechin-galleate ameliorates the development of obliterative airway disease. Exp Lung Res (2011) 0.81
Analysis of the Relationship between Hypertrophy of the Ligamentum Flavum and Lumbar Segmental Motion with Aging Process. Asian Spine J (2016) 0.81
Analysis of the Relationship between Ligamentum Flavum Thickening and Lumbar Segmental Instability, Disc Degeneration, and Facet Joint Osteoarthritis in Lumbar Spinal Stenosis. Asian Spine J (2016) 0.80
A G-CSF functionalized scaffold for stem cells seeding: a differentiating device for cardiac purposes. J Cell Mol Med (2010) 0.80
Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes. PLoS One (2012) 0.79
The role of inflammation in the pathogenesis of macular edema secondary to retinal vascular diseases. Mediators Inflamm (2014) 0.77
Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers. J Am Heart Assoc (2016) 0.77
Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research. Mol Cell Biochem (2016) 0.76
Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy. Inflamm Res (2016) 0.75
Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction. Sci Rep (2016) 0.75
Role of monocyte chemoattractant protein-1 in myocardial infarction. Int J Biomed Sci (2007) 0.75
CARD9 as a potential target in cardiovascular disease. Drug Des Devel Ther (2016) 0.75
Implantation of a Poly-L-Lactide GCSF-Functionalized Scaffold in a Model of Chronic Myocardial Infarction. J Cardiovasc Transl Res (2017) 0.75
Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy. Inflammation (2016) 0.75
RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction. PLoS One (2017) 0.75